Navigation Links
Oncolytics Biotech Inc. Announces 2008 First Quarter Results
Date:4/30/2008

74,400 87,981

-------------------------------------------------------------------------

Other research and development expenses 579,926 552,146

-------------------------------------------------------------------------

-------------------------------------------------------------------------

During the first quarter of 2008, our R&D consulting fees were $27,408 compared to $91,776 for the first quarter of 2007. In the first quarter of 2007, we incurred consulting activity associated with our co-therapy clinical trial applications that was not incurred in the first quarter of 2008.

Our R&D salaries and benefits costs were $478,118 for the first quarter of 2008 compared to $372,389 for the first quarter of 2007. The increase is a result of increases in salary levels for 2008 compared to 2007.

We still expect that our Other R&D expenses will remain consistent with 2007.

Operating Expenses

2008 2007

$ $

-------------------------------------------------------------------------

Public company related expenses 759,970 581,876

Office expenses 324,284 324,839

-------------------------------------------------------------------------

Operating expenses 1,084,254 906,715

-------------------------------------------------------------------------

-------------------------------------------------------------------------

During the first quarter of 2008, our public company related expenses were $759,970 compared to $581,876 for the first quarter of 2007. In the first quarter of 2008, we incurred an increase in professional fees associated with the expansion of our corporate structure, an in
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... Telbec/ - Mirego, leader in mobile strategies and solutions, is ... app extensions for the all new Apple Watch. Made in ... and MediaMiser, these extensions will reinvent the way users receive ... wrist use.  Available today in ... tactile smartwatch that makes for an excellent buddy for business, ...
(Date:4/23/2015)... Athena San Diego, an organization that ... in San Diego’s technology and life science sectors, will ... at their Gala on April 30, 2015 from 5-9pm ... http://athenasd.org/events/ , The Pinnacle Awards recognize individuals ... vision of fostering networking, risk taking and diversity of ...
(Date:4/23/2015)... , April 23, 2015  Neurocrine Biosciences, Inc. ... will report its first quarter 2015 results before the ... will then host a live conference call and webcast to ... Thursday morning, April 30, 2015 at 8:00 a.m. Eastern ... access the live conference call by dialing 866-952-1906 (US) ...
(Date:4/23/2015)... LONDON , April 23, 2015 ... Medical Equipment   Report Details   ... reach a value of $101.3 billion in 2015 and will ... Strong growth in the healthcare sectors around the world and ... the key growth factors in the global healthcare packaging ...
Breaking Biology Technology:Familiprix, OMSignal and MediaMiser apps available today for Apple Watch 2Athena Pinnacle Awards to Honor Executives, Corporations and Educators Working to Promote Women Leaders 2Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results 2Healthcare Packaging Market Forecast 2015-2025 2Healthcare Packaging Market Forecast 2015-2025 3Healthcare Packaging Market Forecast 2015-2025 4Healthcare Packaging Market Forecast 2015-2025 5Healthcare Packaging Market Forecast 2015-2025 6Healthcare Packaging Market Forecast 2015-2025 7Healthcare Packaging Market Forecast 2015-2025 8Healthcare Packaging Market Forecast 2015-2025 9Healthcare Packaging Market Forecast 2015-2025 10
... , NEW YORK , ... NBS ) ("NeoStem" or the "Company"), an international,biopharmaceutical ... , today,announced that it has been awarded a ... Materiel Command, Telemedicine and Advanced Technology,Research Center (USAMRMC-TATRC) under ...
... July 12 Alaska Airlines (NYSE: ... International Airport, Seattle-Tacoma International Airport, Spokane International ... strategic initiative to promote aviation biofuel development in the Pacific ... the United States , the "Sustainable Aviation Fuels Northwest" project ...
... , , ... /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical ... formation of an international clinical advisory panel (the "Panel"). , ... This Panel of international experts with special expertise in ovarian ...
Cached Biology Technology:NeoStem to Receive $700,000 from the U.S. Army's Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds 2NeoStem to Receive $700,000 from the U.S. Army's Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds 3NeoStem to Receive $700,000 from the U.S. Army's Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds 4NeoStem to Receive $700,000 from the U.S. Army's Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds 5Transportation and Aviation Leaders Launch Sustainable Biofuels Initiative 2Transportation and Aviation Leaders Launch Sustainable Biofuels Initiative 3Quest PharmaTech Announces Formation of Clinical Advisory Panel 2Quest PharmaTech Announces Formation of Clinical Advisory Panel 3
(Date:4/10/2015)... , April 10, 2015 Research ... of the "Security Competitive Profiles - NEC" ... , NEC will continue to supply a ... the market, with a company focus on the development ... Winning opportunities in the Asia-Pacific ...
(Date:4/6/2015)... OXFORD, Conn. , Apr. 6, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... it has filed provisional patent 62/143028 for ... CLOSE-PROXIMITY COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces ... wireless payments. This patent surrounds the use of ...
(Date:4/2/2015)... GOTHENBURG, Sweden , April 2, 2015 ... revenues for Q1 2015 attributed to somewhat higher than ... company in the year-end report 2014 that revenues for ... MSEK that the company reported for Q4 2014. The ... continue to be negative. The complete interim report will ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4Fingerprint Cards Revises Revenues for Q1 2015 2
... Patients with type 1 diabetes who used continuous ... experienced significant improvements in blood sugar control, according to ... by the Juvenile Diabetes Research Foundation. Results from the ... the Study of Diabetes (EASD) annual meeting in Rome, ...
... The American College of Clinical Pharmacology (ACCP) has ... PhD , director of Pediatric Clinical Pharmacology at ... Award. Dr. van den Anker, a neonatologist ... and prolific contributions to pediatric clinical pharmacology," according ...
... the choice all too frequently has come down to ... trigger indoor allergens. Today, The Clorox Company extends ... Anywhere® Anti-Allergen Fabric Spray, a new product to help ... Clorox® Anywhere® Anti-Allergen Fabric Spray denatures dust ...
Cached Biology News:JDRF-funded clinical trial demonstrates continuous glucose monitoring improves blood sugar control 2JDRF-funded clinical trial demonstrates continuous glucose monitoring improves blood sugar control 3The Clorox Company's new indoor allergen product reduces common indoor allergens up to 90 percent 2
... Services is a microarray ... industrial and academic researchers. We ... of Agilent, and we provide ... Agilent catalogue arrays. Gene ...
Immunogen GST fusion protein corresponding to full-length rat JNK3/ SAPK1b. Quality Assurance Routinely evaluated by immunoblot. Stability 2 years at -20°C from date of shipment GenBank A...
... post-translational modification that plays an important ... regulation, inflammation, cell-to-cell adhesion, and cell ... lectin based Glycoprotein Isolation Kits, Concanavalin ... (WGA), that allow isolation of glycoproteins ...
... series of laser scanners is the starting ... solution. ,Gene expression analysis, SNP (Single ... essential to the advancement of research in ... novel microarray formats and sizes. These arrays ...
Biology Products: